She blamed irritable bowel syndrome, constipation and even a tight bra. Looking back, she had some classic symptoms of colon ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Melanoma typically results from over-exposure ... showing that its "Integrative-Colon" products killed over 90% of colon ...

A recent in-vitro study reveals that a cannabis extract can potentially decelerate the growth of melanoma cells and increase the rate at which these cells die. Researchers from Charles Darwin ...

Researchers recently tested ChatGPT's ability to diagnose melanoma from dermatoscopic ... Investigator Develop Cancer Therapies A prominent colorectal cancer researcher was recently recognized ...

The study is based on the analysis of human senescent cells in a specific tumor model—melanoma, which affects skin cells known as melanocytes—and, more specifically, melanocytes exposed to ...

Turnstone, which went public via an $80 million IPO in 2023, ended September 2024 with $45.3 million to hand, which the ...

produced rapidly developing tumors. In addition they showed that Nr-CAM is highly expressed in murine and human melanoma cells and human colon cancer tissue, ...

In Canada, colorectal cancer is projected to be the fourth most commonly diagnosed cancer in 2024 (excluding non-melanoma skin cancers), according to the Canadian Cancer Society.

Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.